Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors

Clinical trial NCT05909995 · TERMINATED

Trial details

NCT number: NCT05909995
Sponsor: Incyte Corporation
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma Hepatocellular Carcinoma (HCC)Renal Cell Carcinoma (RCC)Microsatellite Instability - High (MSI-H)Mismatch Repair Deficient (dMMR)Colorectal Carcinoma (CRC)

Start date: 2023-08-29
Primary completion: 2024-09-19
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.